Ensign Peak Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-79,442
| Closed | -$265K | – | 1708 |
|
|
2025
Q1 | $265K | Sell |
79,442
-497,823
| -86% | -$1.66M | ﹤0.01% | 1658 |
|
|
2024
Q4 | $4.27M | Buy |
577,265
+502,673
| +674% | +$3.72M | 0.01% | 689 |
|
|
2024
Q3 | $700K | Hold |
74,592
| – | – | ﹤0.01% | 1505 |
|
|
2024
Q2 | $598K | Buy |
74,592
+8,800
| +13% | +$70.6K | ﹤0.01% | 1553 |
|
|
2024
Q1 | $975K | Buy |
+65,792
| New | +$975K | ﹤0.01% | 1341 |
|
|
2022
Q4 | – | Sell |
-251,371
| Closed | -$2.41M | – | 1992 |
|
|
2022
Q3 | $2.41M | Buy |
251,371
+104,250
| +71% | +$999K | 0.01% | 719 |
|
|
2022
Q2 | $1.62M | Buy |
147,121
+118,661
| +417% | +$1.31M | ﹤0.01% | 893 |
|
|
2022
Q1 | $474K | Sell |
28,460
-225,020
| -89% | -$3.75M | ﹤0.01% | 1571 |
|
|
2021
Q4 | $4.84M | Buy |
253,480
+59,666
| +31% | +$1.14M | 0.01% | 672 |
|
|
2021
Q3 | $4.78M | Buy |
193,814
+156,909
| +425% | +$3.87M | 0.01% | 676 |
|
|
2021
Q2 | $960K | Hold |
36,905
| – | – | ﹤0.01% | 1451 |
|
|
2021
Q1 | $1.17M | Sell |
36,905
-1,460
| -4% | -$46.2K | ﹤0.01% | 1370 |
|
|
2020
Q4 | $1.78M | Sell |
38,365
-610
| -2% | -$28.3K | ﹤0.01% | 1130 |
|
|
2020
Q3 | $1.28M | Buy |
38,975
+11,556
| +42% | +$380K | ﹤0.01% | 1193 |
|
|
2020
Q2 | $753K | Hold |
27,419
| – | – | ﹤0.01% | 1372 |
|
|
2020
Q1 | $821K | Buy |
27,419
+7,285
| +36% | +$218K | ﹤0.01% | 1243 |
|
|
2019
Q4 | $558K | Buy |
+20,134
| New | +$558K | ﹤0.01% | 1493 |
|